Literature DB >> 1865110

Androgen receptor expression in human tissues: an immunohistochemical study.

J A Ruizeveld de Winter1, J Trapman, M Vermey, E Mulder, N D Zegers, T H van der Kwast.   

Abstract

The cellular localization of the human androgen receptor was visualized immunohistochemically using a mouse monoclonal antibody (MAb) F39.4, directed against a fragment of the N-terminal domain of the androgen receptor. The nuclear immunoreactivity of various human tissues with F39.4 was generally consistent with earlier biochemical and autoradiographic data. However, previously suggested androgen receptor expression in thyroid, pancreatic, gastrointestinal, and bladder tissues was not confirmed immunohistochemically. Stratified squamous epithelia of vagina and cervix showed selective immunostaining of the basal cell layer, whereas in the preputial epithelium the intensity of immunoreactivity decreased gradually with maturation. In contrast, glandular epithelia of the sweat glands, male accessory sex organs, and female breast showed nearly exclusive F39.4 staining of the inner cylindric layer. In the testis, Sertoli cells, peritubular myoid cells, and interstitial cells were immunoreactive with MAb F39.4. Expression of the androgen receptor by smooth muscle tissue was largely confined to the male reproductive organs. The specificity and sensitivity of this simple and rapidly performed immunohistochemical technique in the detection of the human androgen receptor at the cellular and subcellular level makes it worthwhile to study tissue androgen receptor expression by immunohistochemistry in physiological and pathological states.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865110     DOI: 10.1177/39.7.1865110

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  47 in total

1.  Alanine aminotransferase regulation by androgens in non-hepatic tissues.

Authors:  Christopher C Coss; Matt Bauler; Ramesh Narayanan; Duane D Miller; James T Dalton
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

2.  Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats.

Authors:  Sarah E Mennenga; Stephanie V Koebele; Abeer A Mousa; Tanya J Alderete; Candy W S Tsang; Jazmin I Acosta; Bryan W Camp; Laurence M Demers; Heather A Bimonte-Nelson
Journal:  Steroids       Date:  2014-08-23       Impact factor: 2.668

3.  Hormone-induced and DNA demethylation-induced relief of a tissue-specific and developmentally regulated block in transcriptional elongation.

Authors:  Manjeet K Rao; Yuiko Matsumoto; Marcy E Richardson; Subbarayalu Panneerdoss; Anjana Bhardwaj; Jacqueline M Ward; Sreenath Shanker; Anilkumar Bettegowda; Miles F Wilkinson
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

4.  Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.

Authors:  Danalea V Skarra; Angelina Hernández-Carretero; Alissa J Rivera; Arya R Anvar; Varykina G Thackray
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

Review 5.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

6.  Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Authors:  Punit Saraon; Natasha Musrap; Daniela Cretu; George S Karagiannis; Ihor Batruch; Chris Smith; Andrei P Drabovich; Dominique Trudel; Theodorus van der Kwast; Colm Morrissey; Keith A Jarvi; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

7.  Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.

Authors:  Tatsuo Masubuchi; Yuichiro Tada; Shin-ichiro Maruya; Yoshiyuki Osamura; Shin-etsu Kamata; Kouki Miura; Chihiro Fushimi; Hideaki Takahashi; Daisuke Kawakita; Seiji Kishimoto; Toshitaka Nagao
Journal:  Int J Clin Oncol       Date:  2014-02-20       Impact factor: 3.402

8.  Do neuroendocrine cells in human prostate cancer express androgen receptor?

Authors:  J L Krijnen; P J Janssen; J A Ruizeveld de Winter; H van Krimpen; F H Schröder; T H van der Kwast
Journal:  Histochemistry       Date:  1993-11

9.  Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.

Authors:  Punit Saraon; Daniela Cretu; Natasha Musrap; George S Karagiannis; Ihor Batruch; Andrei P Drabovich; Theodorus van der Kwast; Atsushi Mizokami; Colm Morrissey; Keith Jarvi; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

10.  ERK regulates calpain 2-induced androgen receptor proteolysis in CWR22 relapsed prostate tumor cell lines.

Authors:  Honglin Chen; Stephen J Libertini; Yu Wang; Hsing-Jien Kung; Paramita Ghosh; Maria Mudryj
Journal:  J Biol Chem       Date:  2009-11-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.